304 related articles for article (PubMed ID: 23376846)
41. High Glucose Triggers Nucleotide Imbalance through O-GlcNAcylation of Key Enzymes and Induces KRAS Mutation in Pancreatic Cells.
Hu CM; Tien SC; Hsieh PK; Jeng YM; Chang MC; Chang YT; Chen YJ; Chen YJ; Lee EYP; Lee WH
Cell Metab; 2019 Jun; 29(6):1334-1349.e10. PubMed ID: 30853214
[TBL] [Abstract][Full Text] [Related]
42. KRAS mutant allele-specific imbalance is associated with worse prognosis in pancreatic cancer and progression to undifferentiated carcinoma of the pancreas.
Krasinskas AM; Moser AJ; Saka B; Adsay NV; Chiosea SI
Mod Pathol; 2013 Oct; 26(10):1346-54. PubMed ID: 23599154
[TBL] [Abstract][Full Text] [Related]
43. EGF receptor signaling is essential for k-ras oncogene-driven pancreatic ductal adenocarcinoma.
Navas C; Hernández-Porras I; Schuhmacher AJ; Sibilia M; Guerra C; Barbacid M
Cancer Cell; 2012 Sep; 22(3):318-30. PubMed ID: 22975375
[TBL] [Abstract][Full Text] [Related]
44. GNAS(R201H) and Kras(G12D) cooperate to promote murine pancreatic tumorigenesis recapitulating human intraductal papillary mucinous neoplasm.
Taki K; Ohmuraya M; Tanji E; Komatsu H; Hashimoto D; Semba K; Araki K; Kawaguchi Y; Baba H; Furukawa T
Oncogene; 2016 May; 35(18):2407-12. PubMed ID: 26257060
[TBL] [Abstract][Full Text] [Related]
45. Loss of Pten and Activation of Kras Synergistically Induce Formation of Intraductal Papillary Mucinous Neoplasia From Pancreatic Ductal Cells in Mice.
Kopp JL; Dubois CL; Schaeffer DF; Samani A; Taghizadeh F; Cowan RW; Rhim AD; Stiles BL; Valasek M; Sander M
Gastroenterology; 2018 Apr; 154(5):1509-1523.e5. PubMed ID: 29273451
[TBL] [Abstract][Full Text] [Related]
46. Mutant KRAS is a druggable target for pancreatic cancer.
Zorde Khvalevsky E; Gabai R; Rachmut IH; Horwitz E; Brunschwig Z; Orbach A; Shemi A; Golan T; Domb AJ; Yavin E; Giladi H; Rivkin L; Simerzin A; Eliakim R; Khalaileh A; Hubert A; Lahav M; Kopelman Y; Goldin E; Dancour A; Hants Y; Arbel-Alon S; Abramovitch R; Shemi A; Galun E
Proc Natl Acad Sci U S A; 2013 Dec; 110(51):20723-8. PubMed ID: 24297898
[TBL] [Abstract][Full Text] [Related]
47. Epithelial tissues have varying degrees of susceptibility to Kras(G12D)-initiated tumorigenesis in a mouse model.
Ray KC; Bell KM; Yan J; Gu G; Chung CH; Washington MK; Means AL
PLoS One; 2011 Feb; 6(2):e16786. PubMed ID: 21311774
[TBL] [Abstract][Full Text] [Related]
48. Oncogenic ERBB2 aberrations and KRAS mutations cooperate to promote pancreatic ductal adenocarcinoma progression.
Li Z; Shao C; Liu X; Lu X; Jia X; Zheng X; Wang S; Zhu L; Li K; Pang Y; Xie F; Lu Y; Wang Y
Carcinogenesis; 2020 Mar; 41(1):44-55. PubMed ID: 31046123
[TBL] [Abstract][Full Text] [Related]
49. Spontaneous induction of murine pancreatic intraepithelial neoplasia (mPanIN) by acinar cell targeting of oncogenic Kras in adult mice.
Habbe N; Shi G; Meguid RA; Fendrich V; Esni F; Chen H; Feldmann G; Stoffers DA; Konieczny SF; Leach SD; Maitra A
Proc Natl Acad Sci U S A; 2008 Dec; 105(48):18913-8. PubMed ID: 19028870
[TBL] [Abstract][Full Text] [Related]
50. YAP1 and TAZ Control Pancreatic Cancer Initiation in Mice by Direct Up-regulation of JAK-STAT3 Signaling.
Gruber R; Panayiotou R; Nye E; Spencer-Dene B; Stamp G; Behrens A
Gastroenterology; 2016 Sep; 151(3):526-39. PubMed ID: 27215660
[TBL] [Abstract][Full Text] [Related]
51. Oncogenic KRAS activates hedgehog signaling pathway in pancreatic cancer cells.
Ji Z; Mei FC; Xie J; Cheng X
J Biol Chem; 2007 May; 282(19):14048-55. PubMed ID: 17353198
[TBL] [Abstract][Full Text] [Related]
52. Oncogenic K-Ras and loss of Smad4 mediate invasion by activating an EGFR/NF-κB Axis that induces expression of MMP9 and uPA in human pancreas progenitor cells.
Bera A; Zhao S; Cao L; Chiao PJ; Freeman JW
PLoS One; 2013; 8(12):e82282. PubMed ID: 24340014
[TBL] [Abstract][Full Text] [Related]
53. Overexpression of heparin-binding EGF-like growth factor in mouse pancreas results in fibrosis and epithelial metaplasia.
Means AL; Ray KC; Singh AB; Washington MK; Whitehead RH; Harris RC; Wright CV; Coffey RJ; Leach SD
Gastroenterology; 2003 Apr; 124(4):1020-36. PubMed ID: 12671899
[TBL] [Abstract][Full Text] [Related]
54. Notch and Kras in pancreatic cancer: at the crossroads of mutation, differentiation and signaling.
De La O JP; Murtaugh LC
Cell Cycle; 2009 Jun; 8(12):1860-4. PubMed ID: 19440048
[TBL] [Abstract][Full Text] [Related]
55. Mouse models of pancreatic cancer.
Herreros-Villanueva M; Hijona E; Cosme A; Bujanda L
World J Gastroenterol; 2012 Mar; 18(12):1286-94. PubMed ID: 22493542
[TBL] [Abstract][Full Text] [Related]
56. Bmi1 is required for the initiation of pancreatic cancer through an Ink4a-independent mechanism.
Bednar F; Schofield HK; Collins MA; Yan W; Zhang Y; Shyam N; Eberle JA; Almada LL; Olive KP; Bardeesy N; Fernandez-Zapico ME; Nakada D; Simeone DM; Morrison SJ; Pasca di Magliano M
Carcinogenesis; 2015 Jul; 36(7):730-8. PubMed ID: 25939753
[TBL] [Abstract][Full Text] [Related]
57. Mutant Kras- and p16-regulated NOX4 activation overcomes metabolic checkpoints in development of pancreatic ductal adenocarcinoma.
Ju HQ; Ying H; Tian T; Ling J; Fu J; Lu Y; Wu M; Yang L; Achreja A; Chen G; Zhuang Z; Wang H; Nagrath D; Yao J; Hung MC; DePinho RA; Huang P; Xu RH; Chiao PJ
Nat Commun; 2017 Feb; 8():14437. PubMed ID: 28232723
[TBL] [Abstract][Full Text] [Related]
58. Preinvasive pancreatic neoplasia of ductal phenotype induced by acinar cell targeting of mutant Kras in transgenic mice.
Grippo PJ; Nowlin PS; Demeure MJ; Longnecker DS; Sandgren EP
Cancer Res; 2003 May; 63(9):2016-9. PubMed ID: 12727811
[TBL] [Abstract][Full Text] [Related]
59. Trisomy of the Dscr1 gene suppresses early progression of pancreatic intraepithelial neoplasia driven by oncogenic Kras.
Lee JC; Shin J; Baek KH
Biochem Biophys Res Commun; 2013 Oct; 440(1):50-5. PubMed ID: 24041692
[TBL] [Abstract][Full Text] [Related]
60. Yap1 activation enables bypass of oncogenic Kras addiction in pancreatic cancer.
Kapoor A; Yao W; Ying H; Hua S; Liewen A; Wang Q; Zhong Y; Wu CJ; Sadanandam A; Hu B; Chang Q; Chu GC; Al-Khalil R; Jiang S; Xia H; Fletcher-Sananikone E; Lim C; Horwitz GI; Viale A; Pettazzoni P; Sanchez N; Wang H; Protopopov A; Zhang J; Heffernan T; Johnson RL; Chin L; Wang YA; Draetta G; DePinho RA
Cell; 2014 Jul; 158(1):185-197. PubMed ID: 24954535
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
